Stimulation of endogenous FGFR2 signalling in estrogen receptor-positive breast cancer cells
Ontology highlight
ABSTRACT: Genome-wide association studies have identified a locus within the second intron of the FGFR2 gene that is consistently the most strongly associated with estrogen receptor-poisive breast cancer risk. However, we know little about the mechanisms by which the FGFR2 locus mediates risk or the pathways in which multiple risk loci may combine to cause disease. Previously, a systems biology approach was adopted to elucidate the regulatory networks operating in MCF-7 breast cancer cells in order to examine the role of FGFR2 in mediating risk. Here, the same approach has been employed using a number of different estrogen receptor-positive breast cancer cell lines in order to see if the previous findings are reproducible and consistent in estrogen receptor-positive disease.
ORGANISM(S): Homo sapiens
PROVIDER: GSE70759 | GEO | 2015/10/05
SECONDARY ACCESSION(S): PRJNA289494
REPOSITORIES: GEO
ACCESS DATA